Open-label Study to Evaluate the Effects of NST-1024 on the PK of Multiple Drugs in Healthy Subjects
Clinical trial NCT05368831 · COMPLETED
Trial details
- NCT number
- NCT05368831
- Sponsor
- NorthSea Therapeutics B.V.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-19
- Primary completion
- 2022-09-07
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.